FDA finds fault with Facebook page; Validic raises $1.25M for data hub;

> Alleged misbranding of a drug on Facebook ($FB) has landed a company in trouble with FDA. News

> Mobile health data aggregator Validic has raised a further $1.25 million and hired executives. Release

> A debate over conflicts of interest is at the center of a Virginia Bioinformatics Institute employment lawsuit. Article

> CRO Parexel ($PRXL) has joined AstraZeneca ($AZN) and Merck ($MRK) on Exostar's cloud-based life sciences hub. Piece

> BioClinica has discussed its role in Pharmacyclics' ($PCYC) accelerated approval. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.